Skip to main content
. 2022 Nov 2;13:1008755. doi: 10.3389/fphar.2022.1008755

TABLE 4.

Changes in tumor markers during neoadjuvant therapy cycles.

AFP(ng/mL) CEA(ng/mL) CA125(U/mL) CA199(U/mL) CA72-4(U/mL)
FC 1.73 2.02 12.60 6.41 24.30
SC 3.26 2.34 7.65 10.50 4.18
TC 3.59 2.59 6.52 5.88 <1.5

FC, first circle; SC, second circle; TC, third circle.